To Compare Blood and Urine Concentrations of Mirabegron (YM178) in Healthy Poor or Extensive Metabolizers for CYP2D6 and to Assess the Effect of Mirabegron on the Metabolism of Metoprolol

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

November 30, 2002

Study Completion Date

November 30, 2002

Conditions

Pharmacokinetics of MirabegronHealthy Subjects

Interventions

DRUG

mirabegron

oral

DRUG

metoprolol

oral

Trial Locations (1)

PRA International (former Pharma Bio-Research), Zuidlaren